Faron to Present at the H.C. Wainwright BioConnect Virtual Conference
Faron Pharmaceuticals Ltd (“Faron”) Faron to Present at the H.C. Wainwright BioConnect Virtual Conference Press Release, January 5, 2022 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET) TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron, will present at the H.C. Wainwright